FIB-4 score and hepatocellular carcinoma risk after hepatitis C virus cure: time to revise surveillance? is a research paper published in HepatoBiliary Surgery and Nutrition (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Research Council
Grant: 671231
Cell circuits as targets and biomarkers for liver disease and cancer prevention
NIAID NIH HHS
Grant: U19 AI123862
European Research Council
Grant: 755460
NIAID NIH HHS
Grant: R03 AI131066
NCI NIH HHS
Grant: R21 CA209940
European Commission
Grant: 862551
A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC)
FWCI
0.11
Citation Percentile
0.4%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals